or Try an Advanced Search...

    Recent News for RNAZ - TransCode Therapeutics, Inc.

    Date Title
    Jun 10 Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
    May 29 TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
    Back to the Main RNAZ Page...